5-Hydroxy-3-methylpicolinonitrile

Catalog No. :
ACFXGT059
CAS No. :
228867-86-5
Molecular Formula :
C7H6N2O
Molecular Weight :
134.14

IUPAC Name:5-hydroxy-3-methylpicolinonitrile

5-Hydroxy-3-methylpicolinonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$70.00Login to see priceIn stockInquiry
250mg97%$135.00Login to see priceIn stockInquiry
1g97%$303.00Login to see priceIn stockInquiry
5g97%$1510.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Hydroxy-3-methylpicolinonitrile
IUPAC Name5-hydroxy-3-methylpicolinonitrile
MDL No.MFCD09879700
Molecular FormulaC7H6N2O
Molecular Weight134.14
SMILESN#CC1=NC=C(O)C=C1C
InChI KeyVFQZBTDFJLSQCM-UHFFFAOYSA-N
Synonym2-Carbonitrile-5-Hydroxy-3-methylpyridine;5-hydroxy-3-Methyl-2-Pyridinecarbonitrile;5-h;5-Hydroxy-3-methylpyridine-2-carbonitrile;2-Pyridinecarbonitrile,5-hydroxy-3-methyl-(9CI);5-HYDROXY-3-METHYLPYRIDINE-2-CARBONITRILE,PURITY:95% MIN(HPLC);2-Pyridinecarbonitrile, 5-hydroxy-3-methyl-;5-hydroxy-3-methylpicolinonitrile
CAS No.228867-86-5
PubChem CID29949734

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H317-H319
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACFXGT059 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBJHZ967 route compound structure diagram
    ACBJHZ967252056-70-5 In Stock
  2. Plus
  3. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7 In Stock
  4. Then
  5. ACFXGT059 route product structure diagram
    ACFXGT059228867-86-5 In Stock
Inquiry

2. ACFXGT059 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGSXY987 route compound structure diagram
    ACGSXY98754232-03-0 In Stock
  2. Then
  3. ACFXGT059 route product structure diagram
    ACFXGT059228867-86-5 In Stock
Inquiry

Comments (0)